225 related articles for article (PubMed ID: 37257519)
21. MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma.
Wu Q; Zhang W; Wang Y; Min Q; Zhang H; Dong D; Zhan Q
Cancer Commun (Lond); 2021 Dec; 41(12):1354-1372. PubMed ID: 34347390
[TBL] [Abstract][Full Text] [Related]
22. Spatial heterogeneity and Immune infiltration of cellular lysosomal pathways reveals a new blueprint for tumor heterogeneity in esophageal cancer.
Wei J; Wu X; Wang S; Liu S; Gao X
Front Endocrinol (Lausanne); 2023; 14():1138457. PubMed ID: 37091857
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein-1-H3K4me3-mediated immune escape in oesophageal squamous cell carcinoma.
Liu J; Zhou WY; Luo XJ; Chen YX; Wong CW; Liu ZX; Bo Zheng J; Yu Mo H; Chen JQ; Li JJ; Zhong M; Xu YH; Zhang QH; Pu HY; Wu QN; Jin Y; Wang ZX; Xu RH; Luo HY
Clin Transl Med; 2023 Sep; 13(9):e1410. PubMed ID: 37712124
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Novel GRHL3/HOPX/Wnt/β-Catenin Proto-oncogenic Axis in Squamous Cell Carcinoma of the Esophagus.
Georgy SR; Rudiatmoko DR; Auden A; Partridge D; Butt T; Srivastava S; Wong N; Swaroop D; Carpinelli MR; Yan F; Bogeski M; Jane SM
Cell Mol Gastroenterol Hepatol; 2023; 15(5):1051-1069. PubMed ID: 36442813
[TBL] [Abstract][Full Text] [Related]
26. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
27. Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Booka E; Tsubosa Y; Yokota T; Mayanagi S; Ishii K; Urakami K; Ohshima K; Ohnami S; Nagashima T; Yamaguchi K
Esophagus; 2021 Oct; 18(4):743-752. PubMed ID: 33826001
[TBL] [Abstract][Full Text] [Related]
28. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing.
Chen XX; Zhong Q; Liu Y; Yan SM; Chen ZH; Jin SZ; Xia TL; Li RY; Zhou AJ; Su Z; Huang YH; Huang QT; Huang LY; Zhang X; Zhao YN; Yun JP; Wu QL; Lin DX; Bai F; Zeng MS
Nat Commun; 2017 Sep; 8(1):524. PubMed ID: 28900112
[TBL] [Abstract][Full Text] [Related]
29. Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma.
Teng H; Xue M; Liang J; Wang X; Wang L; Wei W; Li C; Zhang Z; Li Q; Ran X; Shi X; Cai W; Wang W; Gao H; Sun Z
Theranostics; 2020; 10(7):3035-3048. PubMed ID: 32194853
[No Abstract] [Full Text] [Related]
30. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
31. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
[TBL] [Abstract][Full Text] [Related]
33. Profile of esophageal squamous cell carcinoma mutations in Brazilian patients.
Munari FF; Dos Santos W; Evangelista AF; Carvalho AC; Pastrez PA; Bugatti D; Wohnrath DR; Scapulatempo-Neto C; Guimarães DP; Longatto-Filho A; Reis RM
Sci Rep; 2021 Oct; 11(1):20596. PubMed ID: 34663841
[TBL] [Abstract][Full Text] [Related]
34. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
[TBL] [Abstract][Full Text] [Related]
35. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
36. circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion.
Gu L; Sang Y; Nan X; Zheng Y; Liu F; Meng L; Sang M; Shan B
Mol Cancer; 2022 Dec; 21(1):217. PubMed ID: 36514094
[TBL] [Abstract][Full Text] [Related]
37. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
Yang JW; Choi YL
Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
[TBL] [Abstract][Full Text] [Related]
38. A new murine esophageal organoid culture method and organoid-based model of esophageal squamous cell neoplasia.
Zheng B; Ko KP; Fang X; Wang X; Zhang J; Jun S; Kim BJ; Luo W; Kim MJ; Jung YS; Cervantes CL; Park JI
iScience; 2021 Dec; 24(12):103440. PubMed ID: 34877497
[TBL] [Abstract][Full Text] [Related]
39. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
40. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]